[ALNY] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
07-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 85.51%
YoY- 20.72%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 7,345 18,537 8,275 18,642 20,587 20,897 24,564 -18.21%
PBT -102,974 -51,208 -268,813 -9,575 -11,368 -16,285 -12,305 42.44%
Tax -6,414 -431 -17,870 -562 -414 -1,802 18 -
NP -102,974 -50,777 -250,943 -9,013 -11,368 -16,285 -12,323 42.40%
Tax Rate - - - - - - - -
Total Cost 110,319 69,314 259,218 27,655 31,955 37,182 36,887 20.01%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -1,401.96 -273.92 -3,032.54 -48.35 -55.22 -77.93 -50.17 74.11%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -1.21 -0.62 -3.70 -0.15 -0.25 -0.38 -0.29 26.85%
EPS Diluted -1.21 -0.62 -3.70 -0.15 -0.25 -0.38 -0.29 26.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.